Plasma Epinephrine Contributes to the Development of Experimental Hypoglycemia-Associated Autonomic Failure
Authors:
Open Access
- 9 September 2020
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 105 (11) , 3416-3427
Abstract
Background Recurrent hypoglycemia blunts counter-regulatory responses to subsequent hypoglycemic episodes, a syndrome known as hypoglycemia-associated autonomic failure (HAAF). Since adrenergic receptor blockade has been reported to prevent HAAF, we investigated whether the hypoglycemia-associated rise in plasma epinephrine contributes to pathophysiology and reported interindividual differences in susceptibility to HAAF. Methods To assess the role of hypoglycemia-associated epinephrine responses in the susceptibility to HAAF, 24 adult nondiabetic subjects underwent two 2-hour hyperinsulinemic hypoglycemic clamp studies (nadir 54 mg/dL; 0-2 hours and 4-6 hours) on Day 1, followed by a third identical clamp on Day 2. We challenged an additional 7 subjects with two 2-hour infusions of epinephrine (0.03 μg/kg/min; 0-2 hours and 4-6 hours) vs saline on Day 1 followed by a 200-minute stepped hypoglycemic clamp (90, 80, 70, and 60 mg/dL) on Day 2. Results Thirteen out of 24 subjects developed HAAF, defined by ≥20% reduction in average epinephrine levels during the final 30 minutes of the third compared with the first hypoglycemic episode (P < 0.001). Average epinephrine levels during the final 30 minutes of the first hypoglycemic episode were 2.3 times higher in subjects who developed HAAF compared with those who did not (P = 0.006). Compared to saline, epinephrine infusion on Day 1 reduced the epinephrine responses by 27% at the 70 and 60 mg/dL glucose steps combined (P = 0.04), with a parallel reduction in hypoglycemic symptoms (P = 0.03) on Day 2. Conclusions Increases in plasma epinephrine reproduce key features of HAAF in nondiabetic subjects. Marked interindividual variability in epinephrine responses to hypoglycemia may explain an individual’s susceptibility to developing HAAF.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (DK069861, DK079974)
- Einstein-Mount Sinai Diabetes Research Center (5P30DK020541-41)
- National Center for Advancing Translational Sciences
- Einstein-Montefiore Clinical and Translational Science Awards (UL1TR001073, UL1TR002556)
- American Diabetes Association (1-18-PMF-024)
This publication has 49 references indexed in Scilit:
- Modulation of β-Adrenergic Receptors in the Ventromedial Hypothalamus Influences Counterregulatory Responses to HypoglycemiaDiabetes, 2011
- Death during Intensive Glycemic Therapy of Diabetes: Mechanisms and ImplicationsThe American Journal of Medicine, 2011
- Adrenergic Mediation of Hypoglycemia-Associated Autonomic FailureDiabetes, 2011
- Hypoglycemia-Associated Autonomic Failure Is Prevented by Opioid Receptor BlockadeThe Journal of Clinical Endocrinology & Metabolism, 2009
- Effects of Differing Antecedent Increases of Plasma Cortisol on Counterregulatory Responses During Subsequent Exercise in Type 1 DiabetesDiabetes, 2009
- The Barrier of Hypoglycemia in DiabetesDiabetes, 2008
- Avoidance of Hypoglycemia Restores Hypoglycemia Awareness by Increasing β-Adrenergic Sensitivity in Type 1 DiabetesAnnals of Internal Medicine, 2001
- Effect of Antecedent Hypoglycemia on Cognitive Function and on Glycemie Thresholds for Counterregulatory Hormone Secretion in Healthy HumansDiabetes Care, 1994
- Predictability of chronic intermittent stress: Effects on sympathetic—adrenal medullary responses of laboratory ratsBehavioral and Neural Biology, 1990
- Identification of Type I Diabetic Patients at Increased Risk for Hypoglycemia during Intensive TherapyNew England Journal of Medicine, 1983